Concise Analysis of the International Regenerative Medicine Markets

February 4, 2014

DUBLIN, Feb. 4, 2014 /PRNewswire/ –Research and Markets (http://www.researchandmarkets.com/research/xrndzp/regenerative) has announced the addition of the “Concise Analysis of the International Regenerative Medicine Markets” report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

Regenerative medicine is a way of treating injured and diseased human tissue by using laboratory-grown or therapeutically-induced human tissue as a replacement. As such, astounding new advancements in the ability to repair or replace damaged human tissue and organ functions are being made. Whereas before, remedies for damaged tissue or organ functions due to congenital deformities, injuries, diseases or simple wear-and-tear relied upon either the body’s ability to repair itself (or not), or a surgeon’s skilled hands.

Now, the area of regenerative medicine promises to revolutionize humanity’s ability to remediate countless physical maladies that have perpetually afflicted humans and other animals. Compared to a select few life forms–like the starfish–man-made solutions for tissue repair and organ replacement haven’t come close to nature’s solutions. And where there once was no solution even offered by nature, researchers are now at the cusp of overcoming such limitations by literally regrowing damaged tissue and restoring organ functions through the use of tissue engineering and stem cell therapy. This is the promise of regenerative medicine.

This report discusses the current state of regenerative medicine. The study provides a thorough overview of regenerative medicine sector together with analyses of the funding trends, intellectual property, market opportunities, therapeutic pipeline, research collaborations, partnership activities, and guidelines for establishing new ventures.

The report enables the reader gain in-depth knowledge about ongoing tissue engineering and stem cell therapy research programs carried out in universities and other research centers. Moreover, this analysis profiles the leading companies developing regenerative medicine solutions.

Key Topics Covered:

1. Overview

2. Regenerative Medicines: An Overview of Segments

3. Regenerative Medicine: The Next Evolution of Medical Treatment

4. Recent Advances in Regenerative Medicine and Stem Cell Research

5. Stem Cell Industry Highlights

6. Regenerative Medicines: A Brief Update from Selected Countries

7. Market Analysis for Regenerative Medicine Sector

8. Stem Cell Industry

9. Business Models and Requirements for a Successful Regenerative Medicine Industry

10. Company Profiles

Companies Mentioned:

    --  Aastrom Biosciences, Inc.
    --  Advanced Cell Technology, Inc. (ACT)
    --  Aldagen, Inc.
    --  Alseres Pharmaceuticals, Inc.
    --  Altrika Ltd.
    --  Amgen, Inc.
    --  Amorcyte, Inc.
    --  AnGes MG, Inc.
    --  Angioblast Systems, Inc.
    --  Angion Biomedica, Corp.
    --  Ars Arthro Biotechnology, Inc.
    --  Arteriocyte Medical Systems, Inc.
    --  Athersys, Inc.
    --  BIOMET
    --  BeFutur Biotechnologies
    --  BioE, Inc.
    --  BioLine Rx
    --  BioMimetic Therapeutics, Inc.
    --  BioSafe Group SA
    --  BioTime, Inc.
    --  Bioheart, Inc.
    --  Biovest International, Inc.
    --  BrainStorm Cell Therapeutics, Inc.
    --  Cardio BioSciences
    --  CardioPolymer's Products
    --  CardioPolymers, Inc.
    --  Cardium Therapeutics, Inc.
    --  CaridianBCT
    --  Celgene Corporation
    --  CellSeed, Inc.
    --  Cellartis' Products
    --  Cellerix
    --  Celltrix
    --  Cellular Dynamics International
    --  Cerco Medical
    --  Cook Biotech, Inc.
    --  Cord Blood America (CBAI), Inc.
    --  Cryo-Cell International, Inc.
    --  Curis, Inc.
    --  Cytori Therapeutics, Inc.
    --  Develogen AG
    --  Effector Cell Institute, Inc (ECI)
    --  Epistem plc
    --  FivePrime Therapeutics, Inc.
    --  Forticell Bioscience, Inc.
    --  Gamidia Cell Ltd.
    --  GenVec, Inc.
    --  GeneGrafts Ltd.
    --  Genzyme Corporation
    --  Geron Corporation
    --  Harvest Technologies Corporation
    --  HemaStem Therapeutics, Inc.
    --  HepaLife Technologies, Inc.
    --  Humacyte, Inc.
    --  Hydra Biosciences, Inc.
    --  Integra Lifesciences Holdings Corporation
    --  Intercytex Group plc
    --  International Stem Cell Corporation (ISCO)
    --  Japan Tissue Engineering, Co., Ltd.
    --  Karocell Tissue Engineering AB
    --  Kensey Nash Corporation
    --  Kiadis Pharma, BV
    --  LifeCell
    --  MaxCyte, Inc.
    --  Mesoblast Ltd.
    --  NanoCor's Products
    --  NeuralStem, Inc.
    --  NeuroNova AB
    --  Olympus Terumo Biomaterials Corporation
    --  Opexa Therapeutics, Inc.
    --  Organogenesis, Inc.
    --  Orthovita, Inc.
    --  Osiris Therapeutics, Inc.
    --  Osteotech, Inc.
    --  Pervasis Therapeutics, Inc.
    --  Pleuron's Technology
    --  Pluristem Therapeutics, Inc.
    --  ReNeuron Group plc
    --  RegeneRx
    --  Revivicor, Inc.
    --  Saneron CCEL Therapeutics, Inc.
    --  Sangamo BioSciences, Inc.
    --  Stem Cell Innovations (SCI)
    --  Stem Cell Sciences KK
    --  StemCells, Inc.
    --  SyntheMed, Inc.
    --  Tengion
    --  Thermogenesis Corp.
    --  TiGenix
    --  t cure GmbH

For more information visit http://www.researchandmarkets.com/research/xrndzp/regenerative

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets

Source: PR Newswire

comments powered by Disqus